Evaluating a unique, specialist psychiatric genetic counseling clinic: uptake and impact

People with psychiatric disorders and their family members have expressed interest in receiving genetic counseling (GC). In February 2012, we opened the first (to our knowledge) specialist psychiatric GC clinic of its kind, for individuals with non‐syndromic psychiatric disorders and their families. Prior to GC and at a standard 1‐month follow‐up session, clinical assessment tools are completed, specifically, the GC outcomes scale (GCOS, which measures empowerment, completed by all clients) and the Illness Management Self Efficacy scale (IMSES, completed by those with mental illness). Consecutive English‐speaking clients attending the clinic between 1 February 2012 and 31 January 2013 who were capable of consenting were asked for permission to use their de‐identified clinical data for research purposes. Descriptive analyses were conducted to ascertain demographic details of attendees, and paired sample t‐tests were conducted to assess changes in GCOS and IMSES scores from pre‐ to post‐GC. Of 143 clients, seven were unable to consent, and 75/136 (55.1%) consented. Most were female (85.3%), self‐referred (76%), and had personal experience of mental illness (65.3%). Mean GCOS and IMSES scores increased significantly after GC (p